Atmore Dialysis Center is a medicare approved dialysis facility center in Atmore, Alabama and it has 10 dialysis stations. It is located in Escambia county at 807 East Craig Street, Atmore, AL, 36502. You can reach out to the office of Atmore Dialysis Center at (251) 368-5593. This dialysis clinic is managed and/or owned by Davita. Atmore Dialysis Center has the following ownership type - Profit. It was first certified by medicare in March, 2001. The medicare id for this facility is 012600 and it accepts patients under medicare ESRD program.
Name | Atmore Dialysis Center |
---|---|
Location | 807 East Craig Street, Atmore, Alabama |
No. of Dialysis Stations | 10 |
Medicare ID | 012600 |
Managed By | Davita |
Ownership Type | Profit |
Late Shifts | No |
807 East Craig Street, Atmore, Alabama, 36502 | |
(251) 368-5593 | |
News Archive
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.
C-CIT Sensors AG, today announced the release of its new sensor product allowing to monitor glucose and lactate in-situ and over weeks using one single-use sensor. The product will be exhibited at booth 1732 during the BioProcess International Conference & Exhibition in the Hynes Convention Center, from 4-7 September 2018 and is available for beta testing as of 4 September 2018.
Alcohol and drug-related deaths continue to be a problem in the UK, with the Office for National Statistics reporting that the number of people dying from alcohol and drug abuse has continued to increase over the last decade.
Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department's National Institute of Standards and Technology (NIST) to further develop and scale-up the company's PRINT manufacturing process.
› Verified 4 days ago
NPI Number | 1790740793 |
Organization Name | Atmore Dialysis Center |
Doing Business As | Renal Treatment Centers Southeast Lp |
Address | 807 E Craig St Atmore, Alabama, 36502 |
Phone Number | (251) 368-5593 |
News Archive
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.
C-CIT Sensors AG, today announced the release of its new sensor product allowing to monitor glucose and lactate in-situ and over weeks using one single-use sensor. The product will be exhibited at booth 1732 during the BioProcess International Conference & Exhibition in the Hynes Convention Center, from 4-7 September 2018 and is available for beta testing as of 4 September 2018.
Alcohol and drug-related deaths continue to be a problem in the UK, with the Office for National Statistics reporting that the number of people dying from alcohol and drug abuse has continued to increase over the last decade.
Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department's National Institute of Standards and Technology (NIST) to further develop and scale-up the company's PRINT manufacturing process.
› Verified 4 days ago
Dialysis patients with Hemoglobin data | 35 |
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 29 |
News Archive
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.
C-CIT Sensors AG, today announced the release of its new sensor product allowing to monitor glucose and lactate in-situ and over weeks using one single-use sensor. The product will be exhibited at booth 1732 during the BioProcess International Conference & Exhibition in the Hynes Convention Center, from 4-7 September 2018 and is available for beta testing as of 4 September 2018.
Alcohol and drug-related deaths continue to be a problem in the UK, with the Office for National Statistics reporting that the number of people dying from alcohol and drug abuse has continued to increase over the last decade.
Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department's National Institute of Standards and Technology (NIST) to further develop and scale-up the company's PRINT manufacturing process.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 51 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 502 |
Percentage of adult patients getting regular hemodialysis at the center | 92 |
Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.
C-CIT Sensors AG, today announced the release of its new sensor product allowing to monitor glucose and lactate in-situ and over weeks using one single-use sensor. The product will be exhibited at booth 1732 during the BioProcess International Conference & Exhibition in the Hynes Convention Center, from 4-7 September 2018 and is available for beta testing as of 4 September 2018.
Alcohol and drug-related deaths continue to be a problem in the UK, with the Office for National Statistics reporting that the number of people dying from alcohol and drug abuse has continued to increase over the last decade.
Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department's National Institute of Standards and Technology (NIST) to further develop and scale-up the company's PRINT manufacturing process.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Atmore Dialysis Center with elevated calcium levels.
Patients with hypercalcemia | 51 |
Hypercalcemia patient months | 502 |
Patients with Serumphosphor | 54 |
Patients with Serumphosphor less than 3.5 mg/dL | 10 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 35 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 16 |
Patients with Serumphosphor greater than 7 mg/dL | 14 |
News Archive
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.
C-CIT Sensors AG, today announced the release of its new sensor product allowing to monitor glucose and lactate in-situ and over weeks using one single-use sensor. The product will be exhibited at booth 1732 during the BioProcess International Conference & Exhibition in the Hynes Convention Center, from 4-7 September 2018 and is available for beta testing as of 4 September 2018.
Alcohol and drug-related deaths continue to be a problem in the UK, with the Office for National Statistics reporting that the number of people dying from alcohol and drug abuse has continued to increase over the last decade.
Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department's National Institute of Standards and Technology (NIST) to further develop and scale-up the company's PRINT manufacturing process.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 48 |
Patient months included in arterial venous fistula and catheter summaries | 413 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 53 |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 9 |
News Archive
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.
C-CIT Sensors AG, today announced the release of its new sensor product allowing to monitor glucose and lactate in-situ and over weeks using one single-use sensor. The product will be exhibited at booth 1732 during the BioProcess International Conference & Exhibition in the Hynes Convention Center, from 4-7 September 2018 and is available for beta testing as of 4 September 2018.
Alcohol and drug-related deaths continue to be a problem in the UK, with the Office for National Statistics reporting that the number of people dying from alcohol and drug abuse has continued to increase over the last decade.
Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department's National Institute of Standards and Technology (NIST) to further develop and scale-up the company's PRINT manufacturing process.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 46 |
Hospitalization Rate in facility | 166 (As Expected) |
Hospitalization Rate: Upper Confidence Limit | 304.8 |
Hospitalization Rate: Lower Confidence Limit | 94.4 |
News Archive
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.
C-CIT Sensors AG, today announced the release of its new sensor product allowing to monitor glucose and lactate in-situ and over weeks using one single-use sensor. The product will be exhibited at booth 1732 during the BioProcess International Conference & Exhibition in the Hynes Convention Center, from 4-7 September 2018 and is available for beta testing as of 4 September 2018.
Alcohol and drug-related deaths continue to be a problem in the UK, with the Office for National Statistics reporting that the number of people dying from alcohol and drug abuse has continued to increase over the last decade.
Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department's National Institute of Standards and Technology (NIST) to further develop and scale-up the company's PRINT manufacturing process.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at Atmore Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
Readmission Rate in facility | 27.9 (As Expected) |
Readmission Rate: Upper Confidence Limit | 41.9 |
Readmission Rate: Lower Confidence Limit | 16.5 |
News Archive
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.
C-CIT Sensors AG, today announced the release of its new sensor product allowing to monitor glucose and lactate in-situ and over weeks using one single-use sensor. The product will be exhibited at booth 1732 during the BioProcess International Conference & Exhibition in the Hynes Convention Center, from 4-7 September 2018 and is available for beta testing as of 4 September 2018.
Alcohol and drug-related deaths continue to be a problem in the UK, with the Office for National Statistics reporting that the number of people dying from alcohol and drug abuse has continued to increase over the last decade.
Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department's National Institute of Standards and Technology (NIST) to further develop and scale-up the company's PRINT manufacturing process.
› Verified 4 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Atmore Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
Infection Rate in facility | .65 (As Expected) |
SIR: Upper Confidence Limit | 2.14 |
SIR: Lower Confidence Limit | .11 |
News Archive
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.
C-CIT Sensors AG, today announced the release of its new sensor product allowing to monitor glucose and lactate in-situ and over weeks using one single-use sensor. The product will be exhibited at booth 1732 during the BioProcess International Conference & Exhibition in the Hynes Convention Center, from 4-7 September 2018 and is available for beta testing as of 4 September 2018.
Alcohol and drug-related deaths continue to be a problem in the UK, with the Office for National Statistics reporting that the number of people dying from alcohol and drug abuse has continued to increase over the last decade.
Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department's National Institute of Standards and Technology (NIST) to further develop and scale-up the company's PRINT manufacturing process.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Atmore Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
Patients in facility's Transfusion Summary | 41 |
Transfusion Rate in facility | 75.3 (As Expected) |
Transfusion Rate: Upper Confidence Limit | 162.7 |
Transfusion Rate: Lower Confidence Limit | 38.3 |
News Archive
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.
C-CIT Sensors AG, today announced the release of its new sensor product allowing to monitor glucose and lactate in-situ and over weeks using one single-use sensor. The product will be exhibited at booth 1732 during the BioProcess International Conference & Exhibition in the Hynes Convention Center, from 4-7 September 2018 and is available for beta testing as of 4 September 2018.
Alcohol and drug-related deaths continue to be a problem in the UK, with the Office for National Statistics reporting that the number of people dying from alcohol and drug abuse has continued to increase over the last decade.
Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department's National Institute of Standards and Technology (NIST) to further develop and scale-up the company's PRINT manufacturing process.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at Atmore Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
Patients in facility's Survival Summary | 210 |
Mortality Rate in facility | 19.3 (As Expected) |
Mortality Rate: Upper Confidence Limit | 28.8 |
Mortality Rate: Lower Confidence Limit | 12.4 |
News Archive
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.
C-CIT Sensors AG, today announced the release of its new sensor product allowing to monitor glucose and lactate in-situ and over weeks using one single-use sensor. The product will be exhibited at booth 1732 during the BioProcess International Conference & Exhibition in the Hynes Convention Center, from 4-7 September 2018 and is available for beta testing as of 4 September 2018.
Alcohol and drug-related deaths continue to be a problem in the UK, with the Office for National Statistics reporting that the number of people dying from alcohol and drug abuse has continued to increase over the last decade.
Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department's National Institute of Standards and Technology (NIST) to further develop and scale-up the company's PRINT manufacturing process.
› Verified 4 days ago
News Archive
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.
C-CIT Sensors AG, today announced the release of its new sensor product allowing to monitor glucose and lactate in-situ and over weeks using one single-use sensor. The product will be exhibited at booth 1732 during the BioProcess International Conference & Exhibition in the Hynes Convention Center, from 4-7 September 2018 and is available for beta testing as of 4 September 2018.
Alcohol and drug-related deaths continue to be a problem in the UK, with the Office for National Statistics reporting that the number of people dying from alcohol and drug abuse has continued to increase over the last decade.
Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department's National Institute of Standards and Technology (NIST) to further develop and scale-up the company's PRINT manufacturing process.
› Verified 4 days ago